Description: This report presents initial findings from a project investigating the direct and indirect impacts of COVID-19 in the post-acute phase of the pandemic.

Description: There have been several major disruptions that will likely end up dragging the world into a major regime change. The best way to prepare for the next New Normal is with Scenario Planning. Come join a mock scenario planning exercise working in groups. You will be provided a New Normal Scenario and each group will work to develop a new plan for the transition of a business to successfully navigating that Scenario. Groups will share their scenarios and their plans. Session Coordinators will provide the scenario as well as an outline for a plan to respond to the scenario. Workshop participants will work out details for their scenario and plan in small groups. This session is a follow up to two webcasts sponsored by the JRMS in May and June 2023.

Description: The Actuarial Research Clearing House (ARCH) is an informal communication providing current actuarial research to friends and members of the actuarial community. View the second issue for 2024.

Description: At the conclusion of the session, attendees will be able to understand the potential for using global population health mortality and morbidity data in actuarial contexts. Using the Global Burden of Disease project as a resource, this session will discuss how novel population health research can be used to complement and fill in the gaps of existing input data sources for actuarial analysis and modeling. Presenters will share the latest academic research on the topics of demography, life expectancy, health-adjusted life expectancy, causes of death and disability, comprehensive disease incidence and prevalence metric, measures of disease burden for patients and populations, modifiable risk factors where there are opportunities to make interventions and improve health outcomes, and disparities between and within populations. This research is globally comprehensive and comparable between different markets and disease areas. The session will cover the motivation and purpose of GBD, a brief description of the models used, and dive deep on some selected use cases in actuarial contexts. Audiences will leave with: 1. Understanding challenges and opportunities in measuring disease burden comprehensively and consistently 2. Understanding relevant health metrics, including the drivers of future mortality and morbidity 3. Ideas for applications of epidemiological research in your work

Description: Mortality Improvement is fundamental to setting your mortality assumptions. Creating your own Mortality Improvement assumption may seem like a Herculean task. The truth is creating a mortality improvement assumption with tools provided by the SOA, or the Continuous Mortality Investigation (CMI) make the process easy. Leaving you with the Herculean task of deciding if the assumption you created fits your product. Expect to learn about the CMI tool and the SOA's Mortality Improvement Model (MIM) tool, how you might get data to use in those tools, and what assumptions you need to make outside of data like what will the MI be in 20 or 30 years? Whether it is the general population, a segment of the general population, or certain causes of death, you will get very different answers.

Description: This report updates the Canadian Mortality Data through 2021 in the Human Mortality Database and Canadian Human Mortality Database, including methodology, data sources, and internal consistency checks.

Description: General Session

Description: Some seniors may find it challenging to manage frequent doctor visits. Telemedicine can significantly fill in some of these gaps by enabling “virtual” doctor visits. Telemedicine improves access to medical care, reduces the need for transportation, reduces wait times, protects the health of individuals who won’t be exposed to germs of others in a waiting room, and improves access to care from a healthcare professional who may be far away from the patient and more. Implications for telemedicine in charged amounts (in various insurances) are being worked out and continue to evolve.

Description: Mortality is a fundamental element in the financial projections of the finances of social security programs around the world. Prominent actuaries from the U.S. Social Security Administration, Canada's Office of Superintendent of Financial Institutions and the U.K. Government Actuary's Department will discuss some of the key factors and current issues associated with these projections. Improving mortality has and will have a significant effect on the affordability and importance of income through retirement to many population segments in these countries.

Description: Explore the National Academy of Medicine’s Global Roadmap for Healthy Longevity.AARP has been a primary sponsor of the Roadmap. The Roadmap defines Healthy Longevity as when years of good health approach the biological life span, with physical, cognitive, and social functioning that enables well-being and establishes 2050 as the target year to achieve this goal globally. This Roadmap establishes five overarching principles for healthy longevity.